Literature DB >> 11314011

Human ARF protein interacts with topoisomerase I and stimulates its activity.

L Karayan1, J F Riou, P Séité, J Migeon, A Cantereau, C J Larsen.   

Abstract

The ARF gene (p19(ARF) in mouse and p14(ARF) in man) has become a central actor of the cell cycle regulation process as it participates to the ARF-MDM2-p53 pathway and the Rb-E2F-1 pathway. By use of immunoprecipitation and Western blotting (IP/WB), we now show that ARF physically associates with topoisomerase I (Topo I). ARF-Topo I immune complexes were detected in SF9 insect cells infected with recombinant baculoviruses encoding the two genes as well as in 293 cells that express endogenously these proteins. Preparations of a GST-ARF recombinant protein stimulated the DNA relaxation activity of Topo I but, in contrast, had no effect on the decatenation activity of Topo II. The Topo I stimulation was also detected in cell extracts of SF9 cells expressing both proteins. A confocal microscopy study indicated that part of ARF and Topo I colocalized in the granular component structure of the nucleolus. As a whole, our data indicate that Topo I is a new partner of ARF and suggest that ARF is involved in cell reactions that require Topo I.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11314011     DOI: 10.1038/sj.onc.1204170

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  Activation of human topoisomerase I by protein kinase CK2.

Authors:  Barbara Kowalska-Loth; Agnieszka Girstun; Rafal Derlacz; Krzysztof Staroń
Journal:  Mol Biol Rep       Date:  2003-06       Impact factor: 2.316

2.  Protein kinase CK2 is a central regulator of topoisomerase I hyperphosphorylation and camptothecin sensitivity in cancer cell lines.

Authors:  Keya Bandyopadhyay; Ruth A Gjerset
Journal:  Biochemistry       Date:  2011-01-12       Impact factor: 3.162

Review 3.  Human DNA topoisomerase I: relaxation, roles, and damage control.

Authors:  John B Leppard; James J Champoux
Journal:  Chromosoma       Date:  2005-04-14       Impact factor: 4.316

4.  Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activity.

Authors:  Anindya Goswami; Shirley Qiu; Thomas S Dexheimer; Padhma Ranganathan; Ravshan Burikhanov; Yves Pommier; Vivek M Rangnekar
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

5.  MicroRNAs with a nucleolar location.

Authors:  Joan C Ritland Politz; Eric M Hogan; Thoru Pederson
Journal:  RNA       Date:  2009-07-23       Impact factor: 4.942

6.  ARF function does not require p53 stabilization or Mdm2 relocalization.

Authors:  Chandrashekhar Korgaonkar; Lili Zhao; Modestos Modestou; Dawn E Quelle
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 7.  DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.

Authors:  Ruth A Gjerset
Journal:  J Mol Histol       Date:  2006-07-20       Impact factor: 2.611

8.  PTEN regulation by Akt-EGR1-ARF-PTEN axis.

Authors:  Jianxiu Yu; Sharon S Zhang; Kan Saito; Scott Williams; Yutaka Arimura; Yuliang Ma; Yuehai Ke; Veronique Baron; Dan Mercola; Gen-Sheng Feng; Eileen Adamson; Tomas Mustelin
Journal:  EMBO J       Date:  2008-12-04       Impact factor: 11.598

9.  Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.

Authors:  David Bertwistle; Masataka Sugimoto; Charles J Sherr
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function.

Authors:  Anthony J Apicelli; Leonard B Maggi; Angela C Hirbe; Alexander P Miceli; Mary E Olanich; Crystal L Schulte-Winkeler; Anthony J Saporita; Michael Kuchenreuther; José Sanchez; Katherine Weilbaecher; Jason D Weber
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.